The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to ABOTT Laboratories INC. This is a capital purchase of the Abbott Anility and subsequent 4 years’ service agreement in exercising option years belonging to the Laboratory Branch, Division of Viral Hepatitis. The instrument is an automated immunoanalyzer used for the detection of viral hepatitis serology markers including hepatitis C core antigen, hepatitis E antibodies, and hepatitis D antibodies which are not available on other immunoanalyzers. The subsequent year service agreements include all repairs, labor and travel costs incurred during service calls. This service agreement includes one annual preventative maintenance. All hardware and software updates are included in the agreement.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). The North American Industry Classification System code for this procurement is 334516 Analytical Laboratory Instrument Manufacturing.

Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at rse3@cdc.gov by COB 05 April 2024.